Cancer
Malignant Bladder Neoplasm
CI-CAN-00005866Explore in graph →
Top-level346 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005866Explore in graph →
Clinical trials
1,511 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02665039 | A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function(VINGEM) | completed | Phase 2 | 62 | Dr Anders UllénOTHER | 2 | Oct 8, 2019 | clinicaltrials |
| NCT01589094 | Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer | completed | Phase 2 | 51 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 2, 2019 |
| NCT02648178 | Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers | completed | N/A | 19 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Sep 19, 2019 | clinicaltrials |
| NCT02141490 | Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers | completed | Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 6, 2019 | clinicaltrials |
| NCT02999672 | A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors(KAMELEON) | completed | Phase 2 | 20 | Hoffmann-La RocheINDUSTRY | 4 | Aug 28, 2019 | clinicaltrials |
| NCT03058705 | Near Infrared Fluorescence Imaging for Bladder Cancer Detection | completed | N/A | 10 | Edward MessingOTHER | 1 | Aug 19, 2019 | clinicaltrials |
| NCT02660190 | Photodynamic Diagnosis (PDD) in Flexible Cystoscopy(DaBlaCa-11) | completed | Phase 3 | 696 | Jørgen Bjerggaard JensenOTHER | 1 | Aug 14, 2019 | clinicaltrials |
| NCT01840137 | Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer | completed | N/A | 53 | University of MichiganOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT01373294 | Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer | completed | Phase 2 | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT02300610 | Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer | completed | Phase 1 | 10 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 1, 2019 | clinicaltrials |
| NCT02302807 | A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] | completed | Phase 3 | 931 | Hoffmann-La RocheINDUSTRY | 29 | Aug 1, 2019 | clinicaltrials |
| NCT02716623 | The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Invasive Bladder Cancer(DEAL) | completed | N/A | 5 | University of Kansas Medical CenterOTHER | 1 | Jul 15, 2019 | clinicaltrials |
| NCT00003779 | Biological Therapy in Treating Patients With Bladder Cancer | completed | Phase 3 | 40 | Swiss Cancer InstituteOTHER | 1 | Jun 26, 2019 | clinicaltrials |
| NCT02646319 | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT02355886 | Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy | completed | Phase 2 / Phase 3 | 25 | University of WashingtonOTHER | 1 | Jun 4, 2019 | clinicaltrials |
| NCT02203136 | Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging | completed | — | 16 | M.D. Anderson Cancer CenterOTHER | 1 | May 22, 2019 | clinicaltrials |
| NCT01191892 | Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer | completed | Phase 2 | 82 | Cardiff UniversityOTHER | 1 | May 16, 2019 | clinicaltrials |
| NCT00595088 | Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer | completed | Phase 2 | 47 | Anchiano Therapeutics Israel Ltd.INDUSTRY | 2 | Apr 30, 2019 | clinicaltrials |
| NCT00913536 | Cone Beam Computed Tomography (CT) Bladder | completed | N/A | 30 | University Health Network, TorontoOTHER | 1 | Apr 26, 2019 | clinicaltrials |
| NCT01844947 | Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract(VINSOR) | completed | Phase 1 | 22 | Dr Anders UllénOTHER | 2 | Apr 26, 2019 | clinicaltrials |
| NCT00801762 | Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology | completed | — | 195 | Stanford UniversityOTHER | 1 | Apr 22, 2019 | clinicaltrials |
| NCT03064308 | The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery(POETold) | completed | N/A | 11 | University of NottinghamOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT00526656 | Sunitinib in Treating Patients With Locally Advanced Bladder Cancer | completed | Phase 2 | 9 | Case Comprehensive Cancer CenterOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT02109328 | Alisertib in Chemotherapy-pretreated Urothelial Cancer | completed | Phase 2 | 22 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Apr 11, 2019 | clinicaltrials |
| NCT01166230 | Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB | completed | — | 551 | PhotocureINDUSTRY | 5 | Apr 9, 2019 | clinicaltrials |
| NCT03863028 | Development and Validation of a Simulator-based Test in Transurethral Resection of Bladder Tumors | completed | — | 49 | Rigshospitalet, DenmarkOTHER | 1 | Mar 5, 2019 | clinicaltrials |
| NCT02785887 | Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients(GIVE) | completed | N/A | 233 | Azienda USL 4 PratoOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT00095589 | Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer | completed | — | 125 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 2 | Feb 8, 2019 | clinicaltrials |
| NCT02188446 | Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients(STOP-OP) | completed | N/A | 105 | Rigshospitalet, DenmarkOTHER | 1 | Feb 4, 2019 | clinicaltrials |
| NCT02942121 | Application-based Perioperative Management of the Radical Cystectomy Patient | completed | N/A | 20 | University of Kansas Medical CenterOTHER | 1 | Feb 1, 2019 | clinicaltrials |
| NCT01008865 | A Comparison of the Studer Pouch Versus the T-Pouch Orthotopic Neobladder Urinary Diversion in Bladder Cancer Patients | completed | N/A | 529 | University of Southern CaliforniaOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT00867347 | Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer | completed | Phase 3 | 45 | Institute of Cancer Research, United KingdomOTHER | 1 | Jan 4, 2019 | clinicaltrials |
| NCT03029663 | Complications of Transurethral Resection of the Bladder Tumour(ComTUR) | completed | — | 983 | Medical University of WarsawOTHER | 1 | Dec 28, 2018 | clinicaltrials |
| NCT00004154 | Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer | completed | Phase 3 | 111 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 8, 2018 | clinicaltrials |
| NCT03694535 | Intravesical Thermochemotherapy With Mitomycin-c | completed | N/A | 44 | TC Erciyes UniversityOTHER | 1 | Oct 3, 2018 | clinicaltrials |
| NCT00880334 | Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC | completed | Phase 2 | 149 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT00578526 | SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial(SPRUCE) | completed | Phase 2 | 64 | AHS Cancer Control AlbertaOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT02745301 | Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder | completed | — | 50 | Vanderbilt UniversityOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT00310011 | Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium | completed | Phase 2 | 71 | Wake Forest University Health SciencesOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT00112671 | Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract | completed | Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Jul 27, 2018 | clinicaltrials |
| NCT00900276 | Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants | completed | — | 5 | Wake Forest University Health SciencesOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT02560584 | A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting | completed | Phase 3 | 304 | PhotocureINDUSTRY | 1 | Jul 2, 2018 | clinicaltrials |
| NCT03052504 | Prospective Versus Retrospective Complications in Radical Cystectomy and Nephrectomy | completed | — | 156 | Jørgen Bjerggaard JensenOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT00055601 | Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer | completed | Phase 2 | 97 | Radiation Therapy Oncology GroupNETWORK | 1 | Jun 15, 2018 | clinicaltrials |
| NCT00790569 | Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | completed | N/A | 315 | Butler HospitalOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01180478 | Comparison Study of Narrow Band Imaging Versus White Light Resection in Patients With Bladder Tumors/Cancer | completed | N/A | 965 | Clinical Research Office of the Endourological SocietyOTHER | 0 | Apr 25, 2018 | clinicaltrials |
| NCT01918592 | PET/MRI and Biomarkers in Bladder Cancer(ACEBIB) | completed | N/A | 25 | Turku University HospitalOTHER_GOV | 1 | Apr 18, 2018 | clinicaltrials |
| NCT01836978 | Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy | completed | N/A | 70 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT02214602 | Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer(NMIBCIVT) | completed | Phase 4 | 240 | Mansoura UniversityOTHER | 1 | Mar 22, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Oct 8, 2019source: clinicaltrials